2022, ' The ReIMAGINE prostate cancer risk study protocol : A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses ', PLoS ONE, vol. 17, no. 2, e0259672, pp. e0259672 . https://doi.org/10.1371/journal.pone.0259672